Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.

Clinical and experimental pharmacology & physiology - 1 Apr 2020

Zhou Yuying, Xiang Jingjing, Bhandari Adheesh, Wen Jialiang, Lin Bangyi, Kong Lingguo, Wang Ouchen

Abstract excerpt

The incidence of thyroid cancer has increased in recent decades. The potential molecular mechanisms of papillary thyroid cancer (PTC) are still to be uncovered. In recent years, a number of studies reported that LRRC super family members are up-regulated in cancer cells. Cancer cells can experience a feature change from an epithelial to a mesenchymal phenotype, which is called epithelial-mesenchymal transition...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Epithelial-Mesenchymal Transition

Share to Membrane Proteins

Share to Neoplasm Invasiveness

Share to RNA, Antisense

Share to Thyroid Cancer, Papillary

Source

Identifiers

PMID: 31855284
DOI: 10.1111/1440-1681.13229

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.PMID 31855284Read ↗

Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancerSemantic proximity Read ↗

Identification of key genes and miRNAs markers of papillary thyroid cancerSemantic proximity Read ↗

Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor‐β type I receptor/apoptosis signal‐regulating kinase 1/mitogen‐activated protein kinase signaling axisSemantic proximity Read ↗

MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancerSemantic proximity Read ↗

Overexpression of TPM4 promotes cancer progression through EMT in anaplastic thyroid cancerSemantic proximity Read ↗

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.Semantic proximity Read ↗

Long non‐coding RNA TTN‐AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR‐153‐3p/ZNRF2 axisSemantic proximity Read ↗

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinomaSemantic proximity Read ↗

Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma.Semantic proximity Read ↗

LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.Semantic proximity Read ↗

MicroRNA-196a-5p targeting LRP1B modulates phenotype of thyroid carcinoma cells.Semantic proximity Read ↗

LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β‑catenin signaling pathway and epithelial‑mesenchymal transitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.